Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Lincoff

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
European Heart Journal|May 12, 2000
Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?A M Lincoff, E J Topol
Heart (British Cardiac Society)|January 10, 1998
Antithrombotic therapy with intracoronary stentingS R Steinhubl, A M Lincoff
Seminars in Interventional Cardiology : SIIC|July 16, 1999
Anti-inflammatory stent coatings: dexamethasone and related compoundsS H Park, A M Lincoff
International Journal of Clinical Practice|February 18, 2003
Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarctionP A Gum, A M Lincoff
Circulation|September 1, 1993
Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?A M Lincoff, E J Topol
Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? YesJ E Exaire, A M Lincoff
Journal of Thrombosis and Thrombolysis|March 15, 2001
Platelet glycoprotein IIb/IIIa inhibitors combined with fibrinolytic agents to treat acute myocardial infarctionP L L'Allier, A M Lincoff
Annals of Internal Medicine|July 1, 1996
Anthracycline-induced cardiotoxicityK Shan, A M Lincoff, J B Young
Physics in Medicine and Biology|November 1, 1983
Characterisation of the unsteady transport of labelled species in permeable capillaries: role of convective dispersionA M Lincoff, H S Borovetz, W H Inskeep
Journal of the American College of Cardiology|April 12, 2000
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery diseaseA M Lincoff, R M Califf, E J Topol
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
European Heart Journal|May 12, 2000
Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?A M Lincoff, E J Topol
Heart (British Cardiac Society)|January 10, 1998
Antithrombotic therapy with intracoronary stentingS R Steinhubl, A M Lincoff
Seminars in Interventional Cardiology : SIIC|July 16, 1999
Anti-inflammatory stent coatings: dexamethasone and related compoundsS H Park, A M Lincoff
International Journal of Clinical Practice|February 18, 2003
Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarctionP A Gum, A M Lincoff
Circulation|September 1, 1993
Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?A M Lincoff, E J Topol
Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? YesJ E Exaire, A M Lincoff
Journal of Thrombosis and Thrombolysis|March 15, 2001
Platelet glycoprotein IIb/IIIa inhibitors combined with fibrinolytic agents to treat acute myocardial infarctionP L L'Allier, A M Lincoff
Annals of Internal Medicine|July 1, 1996
Anthracycline-induced cardiotoxicityK Shan, A M Lincoff, J B Young
Physics in Medicine and Biology|November 1, 1983
Characterisation of the unsteady transport of labelled species in permeable capillaries: role of convective dispersionA M Lincoff, H S Borovetz, W H Inskeep
Journal of the American College of Cardiology|April 12, 2000
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery diseaseA M Lincoff, R M Califf, E J Topol
Pageof 12